Nurix Therapeutics (NRIX) EBITDA (2019 - 2026)
Nurix Therapeutics' EBITDA came in at $561.59 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), compared with -$89.36 million a year earlier.
Powered by 
Analysis
Nurix Therapeutics (NRIX) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Aug 31, 2026, Nurix Therapeutics reported EBITDA of $298.37 million; for FY2025 (ended Nov 30, 2025), it was -$276.93 million.
- Going back by fiscal year, EBITDA was -$203.71 million in FY2024, -$147.53 million in FY2023, -$178.52 million in FY2022 and -$115.09 million in FY2021.
- The fiscal Q3 2026 figure represents the highest quarterly EBITDA in data going back to fiscal Q3 2019.
- Business Quant data shows NRIX's EBITDA at -$91.95 million (Q2 2026), -$90.3 million (Q1 2026) and -$80.98 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 561.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 561.59 Mn |
| May 31, 2026 | -91.95 Mn |
| Feb 28, 2026 | -90.30 Mn |
| Nov 30, 2025 | -80.98 Mn |
| Aug 31, 2025 | -89.36 Mn |
| May 31, 2025 | -46.08 Mn |
| Feb 28, 2025 | -60.51 Mn |
| Nov 30, 2024 | -62.11 Mn |
| Aug 31, 2024 | -52.22 Mn |
| May 31, 2024 | -46.21 Mn |
| Feb 29, 2024 | -43.17 Mn |
| Nov 30, 2023 | -43.40 Mn |
| Aug 31, 2023 | -38.06 Mn |
| May 31, 2023 | -24.87 Mn |
| Feb 28, 2023 | -41.20 Mn |
| Nov 30, 2022 | -47.07 Mn |
| Aug 31, 2022 | -45.22 Mn |
| May 31, 2022 | -44.42 Mn |
| Feb 28, 2022 | -41.75 Mn |
| Nov 30, 2021 | -37.19 Mn |
API Access
Nurix Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();